In Depth 16 Jun 2025
Did Novo open the Canadian market to GLP-1 generics?
Find out if Novo’s GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a small fee?
- Latest Posts
In Depth 13 Jun 2025
A new era in migraine treatment: Innovative drugs redefining the field
Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better.
Podcast 13 Jun 2025
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech
In this episode Alex Telford, co-founder of Convoke, explains the work he is doing before opening the door to his insatiable curiosity about the biotech industry.
R&D trends and breakthrough innovations: Chemical & material sustainability
This report identifies the latest trends in sustainable materials and green chemistry R&D, providing scientific decision-makers with a roadmap of high-impact opportunities, emerging technologies, and potential future partners.
News and Trends 11 Jun 2025
Behind the Cure51 deal: Is NVIDIA becoming biotech’s AI infrastructure?
On the occasion of its deal with Cure51, find out about NVIDIA’s biotech strategy as it gets more and more involved in the industry.
In Depth 11 Jun 2025
Can gene therapy treat vision loss?
Since the approval of Luxturna, there has been a wave of companies developing treatments with the potential to cure different forms of genetic blindness.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 10 Jun 2025
Pushing biotech forward in France: 18 companies to know about
France is at the forefront of innovative biotech and Paris has become a vibrant startup ecosystem. Here are 18 top French biotech companies!
News and Trends 9 Jun 2025
First antibiotic in 50 years to tackle superbug nears approval: what’s going on in the field?
Antibiotic development has seen a slump in recent decades. Now, after 50 years, a new antibiotic has been created to tackle bacterial infections.
News and Trends 6 Jun 2025
Beyond CRISPR: What CAST could bring to genome editing
Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in research.
Podcast 6 Jun 2025
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
This week, Paolo Di Giorgio and Regina Hodits of Angelini Ventures share their perspective on the current fundraising landscape.
In Depth 4 Jun 2025
The biggest biotech funding rounds in May 2025
The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in May 2025.
News and Trends 4 Jun 2025
ASCO 2025: key highlights in cancer therapeutics
Discover the major highlights from ASCO, according to researchers and drug developers who attended the convention.
ADVERTISEMENT
